Oncology clinical
Pro Research Analysisby 
Searched over 200M research papers for "oncology clinical"
Consensus Meter
Advances and Guidelines in Oncology Clinical Practice
Breast Cancer Survivorship Care Guidelines
The American Cancer Society and the American Society of Clinical Oncology have developed comprehensive guidelines to assist primary care and other clinicians in managing female adult survivors of breast cancer. These guidelines emphasize the importance of regular surveillance for breast cancer recurrence through cancer-related history and physical examinations, while discouraging routine laboratory or imaging tests in asymptomatic patients . Additionally, primary care clinicians are advised to counsel patients on maintaining a healthy lifestyle, monitor post-treatment symptoms that could affect quality of life, and ensure adherence to endocrine therapy .
Non-Small Cell Lung Cancer Management
The NCCN Clinical Practice Guidelines for Non-Small Cell Lung Cancer (NSCLC) provide a detailed framework for the diagnosis, primary treatment, and surveillance for relapse in NSCLC patients. Notably, patients with metastatic NSCLC who are eligible for targeted therapies or immunotherapies are experiencing longer survival rates. The guidelines focus on the use of targeted therapies for patients with actionable mutations, highlighting the importance of personalized treatment plans .
Systematic Review-Based Consensus Methodology in ASCO Guidelines
The American Society of Clinical Oncology (ASCO) employs a systematic review-based consensus methodology to develop evidence-based guidelines. This approach is particularly crucial in areas with limited high-quality evidence. By using a modified Delphi method, ASCO ensures that recommendations are based on the best available data and achieve a high level of consensus among experts. This methodology has proven effective in addressing complex clinical issues where evidence is sparse.
Multimodality Management in Rectal Cancer
The NCCN Guidelines for Rectal Cancer emphasize the importance of a multimodality approach in managing localized disease. This includes careful patient selection for curative-intent treatments that typically involve a combination of chemotherapy, radiation, and surgical resection. The guidelines provide a comprehensive framework for the diagnosis, staging, and management of rectal cancer, ensuring that patients receive optimal care.
The Role of Artificial Intelligence in Clinical Oncology
Artificial intelligence (AI) is increasingly being integrated into clinical oncology to enhance cancer care. AI applications can synthesize vast amounts of multi-dimensional data, identify patterns, and predict outcomes, thereby improving decision-making for both patients and clinicians. Despite its potential, significant challenges remain in the clinical translation of AI. Addressing these challenges is crucial for the successful integration of AI into individualized patient care.
Progress and Challenges in Cancer Research
The American Society of Clinical Oncology's annual report highlights significant advances in cancer research, including understanding how cancers evade the immune system and why they become resistant to targeted drugs. However, the report also underscores the challenges posed by declining federal funding for cancer research, which threatens the pace of progress. Innovative initiatives like CancerLinQ aim to leverage real-world clinical data to improve cancer care and outcomes.
ASCO Value Framework for Cancer Treatment
The ASCO Value Framework is designed to help physicians and patients assess the value of cancer treatment regimens based on clinical benefit, toxicity, and cost. This framework supports shared decision-making by providing transparent information about the clinical impact and financial implications of different treatment options. The framework is continually updated to reflect new evidence and address patient-specific factors.
Conclusion
The field of clinical oncology is rapidly evolving, with significant advancements in guidelines, treatment modalities, and the integration of new technologies like AI. These developments are crucial for improving patient outcomes and ensuring high-quality cancer care. However, ongoing challenges such as limited evidence in certain areas and declining research funding must be addressed to sustain and accelerate progress in oncology.
Sources and full results
Most relevant research papers on this topic